S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Recent Reports Are A Wake-Up Call For Investors (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Recent Reports Are A Wake-Up Call For Investors (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Recent Reports Are A Wake-Up Call For Investors (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Recent Reports Are A Wake-Up Call For Investors (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary

Inogen Stock Price, News & Analysis (NASDAQ:INGN)

$5.81
+0.82 (+16.43%)
(As of 12/7/2023 ET)
Compare
Today's Range
$5.01
$6.56
50-Day Range
$4.21
$6.03
52-Week Range
$4.13
$26.11
Volume
1.85 million shs
Average Volume
320,758 shs
Market Capitalization
$135.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.67

Inogen MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.75 Rating Score
Upside/​Downside
135.2% Upside
$13.67 Price Target
Short Interest
Bearish
6.65% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.12
Upright™ Environmental Score
News Sentiment
0.39mentions of Inogen in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($3.43) to ($2.48) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.07 out of 5 stars

Medical Sector

428th out of 960 stocks

Surgical Appliances & Supplies Industry

14th out of 17 stocks


INGN stock logo

About Inogen Stock (NASDAQ:INGN)

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; and related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

INGN Stock Price History

INGN Stock News Headlines

Inogen Sees Unusually High Options Volume (NASDAQ:INGN)
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Short Interest in Inogen, Inc. (NASDAQ:INGN) Grows By 52.0%
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Inogen: Q3 Earnings Insights
Inogen Announces Third Quarter 2023 Financial Results
Inogen Inc INGN
Inogen Closes Acquisition Of Physio-Assist SAS
Inogen Completes Acquisition of Physio-Assist
JP Morgan Downgrades Inogen (INGN)
See More Headlines
Receive INGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2023
Today
12/07/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/22/2024

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:INGN
Fax
N/A
Employees
1,026
Year Founded
2001

Price Target and Rating

Average Stock Price Target
$13.67
High Stock Price Target
$26.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+135.2%
Consensus Rating
Reduce
Rating Score (0-4)
1.75
Research Coverage
4 Analysts

Profitability

Net Income
$-83,770,000.00
Pretax Margin
-40.18%

Debt

Sales & Book Value

Annual Sales
$327.86 million
Book Value
$12.98 per share

Miscellaneous

Free Float
23,159,000
Market Cap
$135.42 million
Optionable
Optionable
Beta
1.10

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Michael K. Sergesketter (Age 63)
    Interim Executive Vice President, Chief Financial Officer & Treasurer
    Comp: $227.53k
  • Dr. Stanislav Glezer M.D. (Age 50)
    MBA, Executive VP & CTO
    Comp: $575.8k
  • Mr. Jason Somer (Age 55)
    Executive VP, General Counsel & Corporate Secretary
    Comp: $409.92k
  • Mr. Kevin R. Smith (Age 52)
    President, CEO & Director
  • Ms. Jennifer Yi Boyer
    Executive VP & Chief Human Resources Officer
  • Mr. Vijay Paliwal
    Senior Vice President of Enterprise Enablement
  • Mr. Matthew Pigeon
    Investor Relations Officer














INGN Stock Analysis - Frequently Asked Questions

Should I buy or sell Inogen stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inogen in the last twelve months. There are currently 1 sell rating and 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" INGN shares.
View INGN analyst ratings
or view top-rated stocks.

What is Inogen's stock price target for 2024?

4 Wall Street analysts have issued twelve-month price objectives for Inogen's stock. Their INGN share price targets range from $7.00 to $26.00. On average, they expect the company's stock price to reach $13.67 in the next year. This suggests a possible upside of 135.2% from the stock's current price.
View analysts price targets for INGN
or view top-rated stocks among Wall Street analysts.

How have INGN shares performed in 2023?

Inogen's stock was trading at $19.71 on January 1st, 2023. Since then, INGN shares have decreased by 70.5% and is now trading at $5.81.
View the best growth stocks for 2023 here
.

Are investors shorting Inogen?

Inogen saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 1,550,000 shares, an increase of 52.0% from the October 31st total of 1,020,000 shares. Based on an average trading volume of 277,700 shares, the short-interest ratio is presently 5.6 days.
View Inogen's Short Interest
.

When is Inogen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024.
View our INGN earnings forecast
.

How were Inogen's earnings last quarter?

Inogen, Inc. (NASDAQ:INGN) announced its quarterly earnings data on Tuesday, November, 7th. The medical technology company reported ($1.97) earnings per share for the quarter, missing the consensus estimate of ($0.56) by $1.41. The medical technology company earned $84 million during the quarter, compared to the consensus estimate of $82.09 million. Inogen had a negative net margin of 40.42% and a negative trailing twelve-month return on equity of 30.65%. The firm's revenue was down 20.3% on a year-over-year basis. During the same quarter last year, the company posted ($0.34) EPS.

What guidance has Inogen issued on next quarter's earnings?

Inogen updated its FY 2023 earnings guidance on Tuesday, September, 26th. The company provided EPS guidance of for the period. The company issued revenue guidance of $315.00 million-$320.00 million, compared to the consensus revenue estimate of $316.73 million.

What is Scott Wilkinson's approval rating as Inogen's CEO?

70 employees have rated Inogen Chief Executive Officer Scott Wilkinson on Glassdoor.com. Scott Wilkinson has an approval rating of 46% among the company's employees. This puts Scott Wilkinson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inogen investors own include Puma Biotechnology (PBYI), BioMarin Pharmaceutical (BMRN), Incyte (INCY), (MDVN) (MDVN), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), First Solar (FSLR), Intel (INTC) and Netflix (NFLX).

Who are Inogen's major shareholders?

Inogen's stock is owned by a variety of institutional and retail investors. Top institutional investors include Fred Alger Management LLC (4.59%), Ameriprise Financial Inc. (2.88%), AQR Capital Management LLC (2.62%), Meros Investment Management LP (2.54%), Kent Lake Capital LLC (1.99%) and Jacobs Levy Equity Management Inc. (1.71%). Insiders that own company stock include Alison Bauerlein, Brenton Taylor, Byron Myers, Holdings A/S Novo, Ray Benjamin M Anderson and Raymond Huggenberger.
View institutional ownership trends
.

How do I buy shares of Inogen?

Shares of INGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:INGN) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -